In this study, we demonstrate the developmental activation, in the zebrafish embryo, of a surveillance mechanism which triggers apoptosis to remove damaged cells. We determine the time course of activation of this mechanism by exposing embryos to camptothecin, an agent which specifically inhibits topoisomerase I within the DNA replication complex and which, as a consequence of this inhibition, also produces strand breaks in the genomic DNA. In response to an early (pre-gastrula) treatment with camptothecin, apoptosis is induced at a time corresponding approximately to mid-gastrula stage in controls. This apoptotic response to a block of DNA replication can also be induced by early (pre-MBT) treatment with the DNA synthesis inhibitors hydroxyurea and aphidicolin. After camptothecin treatment, a high proportion of cells in two of the embryo's three mitotic domains (the enveloping and deep cell layers), but not in the remaining domain (the yolk syncytial layer), undergoes apoptosis in a cell-autonomous fashion. The first step in this response is an arrest of the proliferation of all deep-and enveloping-layer cells. These cells continue to increase in nuclear volume and to synthesize DNA. Eventually they become apoptotic, by a stereotypic pathway which involves cell membrane blebbing, "margination" and fragmentation of nuclei, and cleavage of the genomic DNA to produce a nucleosomal ladder. Fragmentation of nuclei can be blocked by the caspase-1,4,5 inhibitor Ac-YVAD-CHO, but not by the caspase-2,3,7[,1] inhibitor Ac-DEVD-CHO. This suggests a functional requirement for caspase-4 or caspase-5 in the apoptotic response to camptothecin. Recently, Xenopus has been shown to display a developmental activation of the capability for stress-or damaged-induced apoptosis at early gastrula stage. En masse, our experiments suggest that the apoptotic responses in zebrafish and Xenopus are fundamentally similar. Thus, as for mammals, embryos of the lower vertebrates exhibit the activation of surveillance mechanisms, early in development, to produce the selective apoptosis of damaged cells.
INTRODUCTION
In mammals, specific surveillance mechanisms operate in somatic tissues to remove damaged cells from proliferative subpopulations. These mechanisms act either by inducing permanent cell-cycle arrest (Di Leonardo et al., 1995; Serrano et al., 1997; Linke et al., 1996; Wahl et al., 1997) or by inducing apoptosis (Enoch and Norbury, 1995; Kastan et al., 1995; Morgan and Kastan, 1997) . Recent studies on embryos and embryonic cell lines from mice (employing strains which are either wild-type or null for the p53, p21, or ATM genes) indicate that such surveillance mechanisms become activated well before birth and possibly even before embryonic day E3.5 (Deng et al., 1995; Norimura et al., 1996; Brison and Schultz, 1997; Herzog et al., 1998; Aladjem et al., 1998) . A similar (surveillancerelated) apoptotic response appears to occur in the human embryo, as early as blastocyst stage (Jurisicova et al., 1996) . These studies raise a number of important questions. (1) When, in early development, is this surveillance capability first acquired? (2) What molecular mechanisms underlie the capability? (3) Do the mechanisms vary between different lineages, tissues, or developmental stages in the early embryo? (4) Is the surveillance capability also present in the lower vertebrates?
Recently, several laboratories have described a stress-or damage-induced apoptotic response in Xenopus, which first appears at the gastrula stage (Stack and Newport, 1997; Sible et al., 1997; Hensey and Gautier, 1997; . This response can be induced by treating embryos with a variety of agents including ␥-irradiation, hydroxyurea, cycloheximide, ␣-amanitin, and emetine. In Xenopus, this response becomes inducible at roughly the same time as the earliest "developmental" apoptotic events that are involved in tissue-remodeling (Hensey and Gautier, 1998) . Evidence suggests that the response may be regulated partly by maternal factors, supplied in the oocyte. Thus Xenopus, like mouse, appears to have a mechanism for detecting damaged cells, and for removing these cells by apoptosis, beginning quite early in development. It is important to characterize this response in other lower vertebrates and to delineate the similarities and differences in the mechanism of this response between species.
Recently, our laboratory has identified a similar damageor stress-induced apoptotic response in embryos of the zebrafish Danio rerio. We have shown that treatment of zebrafish embryos with the spindle-depolymerizing agent nocodazole will produce apoptosis, beginning approximately at mid-gastrula stage (Ikegami et al., 1997b) . We have also developed a novel cell-free system from gastrulastage zebrafish embryos, which allows apoptotic events to be studied at the biochemical level and which permits intermediates in the apoptotic destruction of nuclei and chromosomes to be trapped and imaged at high spatial resolution (Chan and Yager, 1998) .
Here, we extend our previous studies by demonstrating that the zebrafish embryo exhibits a precisely timed, developmental activation of the capability for apoptosis in response to treatment with three agents which block DNA replication (HU, 2 aphidicolin, camptothecin). Most of our experiments were done with camptothecin, which is a highly specific topoisomerase I inhibitor. Topoisomerase I is an integral component of the multiprotein DNA replication complex (Applegren et al., 1995; Simbulan-Rosenthal et al., 1996) . Camptothecin acts by irreversibly trapping a nicked-DNA transition state (Hsiang et al., 1985; Svejstrup et al., 1991; Redinbo et al., 1998) . Thus, in addition to directly inhibiting the catalytic function of topoisomerase I (and thereby blocking DNA replication), camptothecin causes the production of strand breaks in the genomic DNA. In mammalian cells, DNA strand breaks are extremely potent inducers of both cell-cycle arrest (Di Leonardo et al., 1994; Linke et al., 1997) and apoptosis (Enoch and Norbury, 1995; Kastan et al., 1995; Morgan and Kastan, 1997) .
This study is a continuation of earlier work (Ikegami et al., 1997a) which demonstrated that, before the midblastula transition (MBT), in response to camptothecin treatment, the zebrafish embryo is unable either to arrest the proliferation of cells or to undergo apoptosis. Instead, exposure to camptothecin before MBT prevents the completion of S phase and yet allows entry into mitosis, suggesting that (as in Xenopus, sea urchin, Drosophila, etc.) the "DNA synthesis completion" checkpoint is absent or nonfunctional before MBT (see Ikegami et al., 1997a) . After MBT, camptothecin efficiently produces an arrest of cell proliferation in two of the zebrafish embryo's three mitotic domains (the deep and enveloping cell layers) (Ikegami et al., 1997a) . Thus, after MBT, a negative selection of cells with impaired capability for DNA replication, or with genomic DNA damage, becomes a formal possibility in the zebrafish embryo and could be achieved via cell-proliferation arrest.
The present study shows that, after midgastrula stage, the zebrafish embryo employs apoptosis, in preference to cellproliferation arrest, to eliminate cells which have been exposed to (and damaged by) camptothecin. We show that this response displays the features of classical apoptosis, is acquired by a cell-autonomous timing mechanism, and can be blocked by the caspase-1,4,5 inhibitor Ac-YVAD-CHO. We also show that, as the zebrafish embryo proceeds further through development, lineages and tissues begin to differ in the capability to mount this response. Finally, we show that an early (pre-MBT) treatment with camptothecin (or with the alternative DNA replication blockers aphidicolin or hydroxyurea) will produce embryo death by apoptosis, approximately at mid-gastrula stage, but not before this time. This aspect of the response appears fundamentally similar to what has recently been described in Xenopus (Stack and Newport, 1997; Hensey and Gautier, 1997; Anderson et al., 1997; Sible et al., 1997) .
The above-cited studies in Xenopus, combined with our studies in zebrafish, reveal clearly that the lower vertebrates have evolved a sophisticated mechanism for detecting and eliminating damaged cells. Remarkably, this mechanism is activated early in development, possibly even before cell lineages become fully committed. As have others (Stack and Newport, 1997; Hensey and Gautier, 1997) , we hypothesize that such a mechanism may "purge" the embryo of defective cells, which were inadvertently generated during the cleavage phase of development. This would prevent such defective cells from contributing to critical lineages later in development. 2 Abbreviations used: Br-dU, bromodeoxyuridine; BSA, bovine serum albumin; D-MEM, Dulbecco's modified Eagle medium; DMSO, dimethyl sulfoxide; ES, embryonic stem; EVL, enveloping epithelial cell monolayer; FACS, fluorescence-activated cell-sorting; HU, hydroxyurea; MBT, midblastula transition; MZT, maternal-to-zygotic transition; PBS, phosphate-buffered saline; TdT, terminal deoxynucleotidyl transferase; TRITC, tetramethyl rhodamine isothiocyanate; TUNEL, TdT-mediated nick end labeling assay; YSL, yolk syncytial layer.
MATERIALS AND METHODS

Reagents, Buffers, and Media
Water was obtained from a Milli-Q system (Millipore, Bedford, MA). Sea salts for aquaculture were "scientific grade" from Coralife (Torrance, CA). Buffers and salts for biochemical experiments were ACS reagent grade or better. Camptothecin, aphidicolin, and hydroxyurea were from Sigma (St. Louis, MO). TRITC-conjugated goat anti-mouse IgG (fluorophore:protein molar ratio 2.7) was from Sigma. Texas red-conjugated anti(digoxygenin) (fluorophore:protein molar ratio 2.4) was from Jackson ImmunoResearch (West Grove, PA). Anti(Br-dU) and murine laminin were from Boehringer Mannheim. Teflon-coated glass microscope slides, with 5-mmdiameter glass-bottomed wells, were from Cel-Line (Newfield, NJ). These slides were rendered suitable for culture of dissociated blastomeres by incubation in 10 g/ml murine laminin in sterile PBS, at 25°C for 45 min, followed by a rinse with Milli-Q water.
We employed the following buffers and culture media: PBS-as in Westerfield et al. (1995) ; PBT, PEM-as in Patel et al. (1989) ; SSC, TBE, TE-as in Sambrook et al. (1989) ; PDT-1ϫ PBS, 1% DMSO, 0.1% Tween 20; high-EDTA buffer-10 mM Tris-HCl, 100 mM EDTA, 0.5% SDS (pH 7.8); blocking solution-PDT ϩ 1% BSA ϩ 2% goat serum; hybridization buffer-5ϫ SSC, 1% Sarkosyl L-30, 50 g/ml salmon sperm DNA; fish water-Milli-Q-purified water ϩ 60 mg/L sea salts; Ringer's solution, Ca 2ϩ -depleted Ringer's solution-as in Westerfield et al. (1995) ; zebrafish cell-culture medium-D-MEM/F-12 (Gibco BRL), supplemented with 5% fetal calf serum, 10% extract of 3-day-old zebrafish embryos (prepared as in Westerfield, 1995) , and 1% penicillin-streptomycin (ES cellqualified grade; Gibco BRL).
Aquaculture and Embryology
Adult wild-type zebrafish (D. rerio) were obtained from a commercial breeder (Big Al's Aquarium Services, Toronto) or were raised from fertilized eggs in our own laboratory. Aquaculture methods were adapted from Westerfield (1995) , and embryos were staged according to Kimmel et al. (1995) . Embryos from each photo-induced tank mating were synchronous to within one cell cycle, through midblastula stage.
Treatment of Embryos with Camptothecin, Aphidicolin, or Hydroxyurea
At sphere to 30% epiboly stage (4.0 -4.7 h development at 28.5°C), embryos were placed in fish water containing a preselected concentration of camptothecin (1, 10, 30, or 60 M), aphidicolin (1, 5, or 25 g/ml, equivalent to 3, 15, or 75 M), or hydroxyurea (30 mM). The embryos were examined at 50 -80ϫ total magnification, to assess their morphology and progression through development. At selected time points, embryos either were fixed with 4% formaldehyde in PEM for whole-mount assays (Patel et al., 1989) or were frozen in a dry ice/ethanol bath for chromatin-fragmentation assays.
Culture of Dissociated Blastomeres
At the germ-ring to shield stage (5.7-6.0 h development at 28.5°C), embryos were manually dechorionated and transferred to Ringer's solution. The yolk was removed and the cellular explants were transferred to separate wells of a glass depression slide, which contained 50 -100 l of calcium-free Ringer's solution. After incubation for 5-10 min at 28.5 Ϯ 0.5°C, the individual explants were dissociated into single cells by gentle passage through a Gilson P-200 micropipette tip (400-m inner diameter). The extent of dissociation was monitored at 40ϫ magnification under a dissecting microscope.
A 15-l suspension of dissociated cells was transferred to a laminin-coated well of a Cel-Line microscope slide, and then 85 l of zebrafish cell-culture medium was added. Apoptosis was induced in this dissociated cell culture by adding camptothecin to a final concentration of 60 M and incubating at 28.5 Ϯ 0.5°C in a humid chamber. At 7 h postfertilization, and at hourly intervals thereafter, samples of dissociated cells were fixed with 2% formaldehyde for 3 h at 25°C, stained with 1 g/ml Hoechst 33258 for 20 min, and examined by epifluorescence and phase-contrast microscopy.
Treatment of Embryos with Camptothecin ؉ Caspase Inhibitors
At the germ-ring stage (5.5 h development at 28.5°C), embryos were exposed to 250 or 500 M caspase-1,4,5 inhibitor Ac-YVAD-CHO or caspase-2,3,7[,1] inhibitor Ac-DEVD-CHO. Then, at shield stage (30 min after the addition of the caspase inhibitor), a subset of these embryos received an additional treatment of 60 M camptothecin. At hourly intervals, four or five replicate embryos were removed to 4% formaldehyde in PEM (Patel et al., 1989) , stained with Hoechst 33258, prepared as "flattened whole mounts" (see below), and examined by epifluorescence microscopy. Apoptotic nuclei were quantitated by sampling replicate microscopic fields.
Whole-Mount Assays
Flattened whole mounts. Flattened whole mounts were prepared by the method of Yager et al. (1998) and were examined under a Zeiss Axioskop or Leica TCS4D confocal microscope. The volumes (V) of individual nuclei were estimated from (x, y) projections, in the following manner. We define a as the major axis in the (x, y) plane, b as the minor axis in the (x, y) plane, and c as the axis in the z direction, implying V ϭ 4 3 a b c. If we assume a prolate ellipsoid shape, then b ϭ c. In fact, a slight error is introduced by this assumption. We have determined, by confocal microscopy, that a slight "squashing" of nuclei occurs in the z dimension, in flattened whole mounts, implying that b c. However, this probably introduces no more than ϳ10 -20% error in estimated volume (calculation not shown). Such an error is small, relative to the large changes in nuclear volume which we measure (see Fig.  6A ).
Fluorescent TUNEL assay. DNA fragmentation during apoptosis was detected with the TUNEL assay (Gavrieli et al., 1992; Grasl-Kraupp et al., 1995) . The Oncor "ApopTag" kit was modified to allow a fluorescent readout, by means of Texas red-conjugated anti-digoxygenin, in flattened whole mounts. As a negative control, we omitted the TdT enzyme, which led to a complete absence of TUNEL signal (not shown). As a positive control, embryos were exposed to DNase I before the assay, which produced an intense TUNEL signal in all nuclei and mitotic chromosome sets (not shown).
Br-dU incorporation assay. Embryos were dechorionated in Ringer's solution in agarose-coated petri dishes. One set of embryos was treated with 60 M camptothecin for 30 min, while another set of embryos was left untreated as a control. Next, Br-dU was added to a final concentration of 10 mM in a 2% DMSO carrier. After 3 h incubation, the embryos were fixed 3 h in 4% formaldehyde in PEM. They were then washed five times in PBS and twice in 100% methanol and stored in 100% methanol at Ϫ20°C, for later analysis.
Embryos were rehydrated via a graded series of methanol/PBS washes. After rehydration, the embryos were placed in PDT for 20 min, washed twice with 1% DMSO, and then washed twice with 2 N HCl. Next, the embryos were incubated in 2 N HCl for 1 h at 37°C, washed three times for 15 min in PDT buffer, and then washed for 20 min in blocking solution. Embryos were then incubated in blocking solution ϩ 6 g/ml mouse monoclonal anti-Br-dU, either for 2 h at room temperature on a rotary shaker or overnight at 4°C with no shaking. Embryos were washed 4ϫ for 15 min in PDT and then incubated in blocking solution ϩ 6 g/ml TRITC-conjugated goat anti-mouse IgG for 2 h in the dark on a rotary shaker. After staining, the embryos received four 15-min washes in PDT, followed by three 15-min washes in PBS on a rotary shaker, and were converted into flattened whole mounts.
Distinction between Arrest of Cell Proliferation and Arrest of the Cell Cycle; Operational Definitions Used in This Study
Several conceptual and measurement issues underlie our observations (below) that camptothecin can induce an arrest of cell proliferation in the post-MBT zebrafish embryo. A clarification at this point in the article will be advantageous.
(1) A complete view of a cell's progression through the cell cycle requires two reference frames and two types of experimental measurement. A "cell-biological" approach would measure the events of mitosis and cell division, while a "biochemical" viewpoint would measure oscillations in the underlying cell-cycle engine (synthesis and breakdown of cyclin B, increase and decrease of cdc2 kinase activity, etc.).
(2) Our experimental assays, which are based on epifluorescence microscopy, measure the behavior of nuclei and mitotic figures. Thus we view the embryo chiefly from a cell-biological reference frame, and we can only speak of an "arrest of cell proliferation." We have not tried to measure the underlying biochemical state of the cell-cycle engine. Therefore, we cannot meaningfully speak of an "arrest of the cell cycle" from the biochemical reference frame.
(3) There is also a deeper conceptual point. Can a bona fide cell-cycle arrest even be possible, if the cell cycle does not exhibit gap (G 1 , G 2 ) phases? Do cells of the zebrafish embryo have an "adult" form of the cell cycle (with the G 1 and G 2 phases), over the period of interest?
This study is concerned with the zebrafish embryo's response to camptothecin, starting at MBT. Zamir et al. (1997) have shown, by FACS analysis, that a population of nuclei with 2N DNA content, and therefore by inference a G 1 phase, appears at MBT. However, the measurement technique of Zamir et al. could not distinguish between M and G 2 nuclei (because both would have 4N DNA content); thus it currently is unknown when, in development, the G 2 phase appears. It is reasonable to hypothesize that a camptothecin-induced arrest of cell proliferation might be due to a bona fide arrest of the underlying cell cycle, at the biochemical level, in the G 1 phase. However, additional experimental work, not performed in this study, must be done to address this point directly.
Gel Electrophoresis Assays for Cleavage of Genomic DNA
Replicate sets of 40 embryos were incubated in 60 M camptothecin from 6 to 9 h postfertilization and then frozen in a dry ice/ethanol bath. For analysis, each frozen sample received a 100-l aliquot of high-EDTA buffer and was homogenized on ice. The high-EDTA buffer completely inhibited an endogenous nuclease which otherwise would become activated during homogenization, to produce an oligonucleosomal ladder (data not shown). Samples were extracted with phenol, precipitated with ethanol, resuspended in TE ϩ 5% glycerol, and examined on 1.2% agarose gels, using a (123) n bp ladder (Gibco BRL) as a size marker. Gels were stained with 0.5 g/ml ethidium bromide and photographed on a UV transilluminator with 3000 ASA Polaroid film, using a Tiffen No. 15 deep-yellow filter.
DNA bands were transferred from agarose gels to nylon membranes, using the "fast downward blot" method of Zhou et al. (1994) . The membranes were rinsed in 2ϫ SSC, air-dried, crosslinked with UV light ( ϭ 254 nm, 120 mJ/cm 2 ), incubated 18 h at 42°C in hybridization buffer, and probed at 42°C with a randomly primed, 32 P-labeled zebrafish total genomic DNA probe. After 18 h of incubation, the membranes were washed with a series of buffers containing 0.1% SDS and decreasing concentrations (2ϫ, 1ϫ, 0.5ϫ) of SSC. Southern blots were visualized either by autoradiography with Kodak X-Omat X-ray film or by means of a PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
RESULTS
Developmental Regulation of the Capability to Undergo Damage-Induced Apoptosis
Topoisomerase I is an essential component of the multiprotein DNA replication complex (Applegren et al., 1995; Simbulan-Rosenthal et al., 1996) . The alkaloid camptothecin is a highly specific inhibitor of topoisomerase I. As a direct consequence of its mode of action (which involves trapping a nicked-DNA transition state), camptothecin also induces strand breaks in the genomic DNA (Hsiang et al., 1985; Svejstrup et al., 1991; Redinbo et al., 1998) . When zebrafish embryos are treated with camptothecin after MBT, either of two responses-an arrest of cell proliferation or apoptosis-can be observed, depending on when the treatment is applied and when the embryos are examined. Figure 1 presents an experiment which clearly illustrates the difference between the two types of response. In this experiment, a synchronous population of embryos was transferred into 60 M camptothecin at early gastrula stage (6 h postfertilization) and was then assayed for cellproliferation arrest or apoptosis, using the flattened wholemount method. This method of examination, based on epifluorescence microscopy, allows all nuclei from a zebrafish embryo to be visualized, up to the 10,000-cell (late gastrula) stage . An example of a single embryo, stained with Hoechst 33258 and prepared as a flattened whole mount, is shown in Fig. 1A . All nuclei are clearly visible under 100ϫ total magnification and can be examined in detail under 1000ϫ total magnification.
(1) When embryos were transferred into 60 M camptothecin at 6 h postfertilization and then assayed within 1 h, a rapid and complete stop of cell proliferation was observed (Fig. 1B) . We have shown elsewhere that this reflects a sudden drop of the mitotic index from a value of 0.07 to a value of 0.00 (Ikegami et al., 1997a) . It has been shown by FACS analysis that cells of the zebrafish embryo acquire the G1 phase as they enter MBT (Zamir et al., 1997) ; this is consistent with the hypothesis that a checkpoint capability is acquired at MBT. We have hypothesized (Ikegami et al., 1997a ) that this response derives from the operation of a set of cell-cycle checkpoints, which become active at MBT and which monitor either for impeded DNA replication or for the presence of DNA strand breaks. In the Xenopus embryo, a comparable set of checkpoints becomes activated at MBT (Newport and Dasso, 1989; Dasso and Newport, 1990; Smythe and Newport, 1992; Walker et al., 1992) .
(2) If camptothecin-treated zebrafish embryos are transferred to 60 M camptothecin at 6 h and then examined at 7 h or later, a qualitatively different response, which appears to be apoptosis, is seen. Figure 1C plots the total number of apoptotic cells per embryo, and also the percentage of the embryo's cells which are apoptotic, as a function of time after the exposure to camptothecin is begun. The capability to undergo camptothecin-induced apoptosis appears only after 7 h postfertilization, regardless of how much earlier than this a camptothecin treatment is applied. The 7 h time point corresponds to mid-gastrula stage in untreated control embryos.
The fraction of cells which become apoptotic in a camptothecin-treated embryo increases in proportion to the length of the treatment. For example, if 60 M camptoproliferation and for apoptosis. All assays were conducted in the flattened whole-mount format. (A) Example of 4-h-old control embryo, stained with Hoechst 33258 and examined under epifluorescence with a 10ϫ (NA 0.5) objective. Scale bar ϭ 100 m. Higher power objectives were used to obtain a more detailed view of individual nuclei within such a mount. (B) Arrest of cell proliferation, assayed by counting the number of nuclei per microscopic field at different times after the start ( Խ ) of camptothecin exposure.
Open circles-untreated control embryos. Closed circlesembryos treated at 6 h with 60 M camptothecin and then examined at successive times under a 40ϫ (NA 0.75) objective. (C) Apoptosis, as revealed by estimating the number and percentage of fragmented nuclei per embryo. Exposure to 60 M camptothecin began at 6 h postfertilization. Open circles-untreated control embryos. Closed circles-embryos treated at 6 h with 60 M camptothecin and then examined at successive times under a 40ϫ (NA 0.75) objective. At these time points, apoptotic cells were rare enough that every one in an embryo could be counted. Closed squares-embryos examined at 10, 11, and 12 h under a 100ϫ (NA 1.30) oil-immersion objective. At these time points, apoptotic cells were so common that their numbers could be estimated by sampling replicate microscopic fields. In (C), error bars lie within the widths of the individual points.
FIG. 1.
The capabilities to undergo camptothecin-induced arrest of cell proliferation and apoptosis show different developmental time courses. Untreated control embryos were examined at a series of times, to estimate the baseline for cell number and mitotic index. At the shield stage (6 h postfertilization), a subset of embryos was treated with 60 M camptothecin. Then, at subsequent times, both treated and untreated embryos were assayed for arrest of cell thecin is applied to an embryo at 6 h postfertilization, then by 12 h (early somitogenesis stage), apoptosis is observed in ϳ65% of its cells, at which point the embryo dies. Embryos which have been exposed to 60 M camptothecin for a critical length of time (1 h or possibly less) at a stage before somitogenesis will proceed inevitably to a final state of cellular and embryonic death. This fate cannot be prevented by transferring the exposed embryos to camptothecin-free media (see below). Once a zebrafish embryo acquires the capability to respond to camptothecin by undergoing apoptosis, then this response can be triggered very rapidly. Thus, if an embryo is treated with 60 M camptothecin beginning at 9.5 h postfertilization, some fraction of its cells begin to undergo apoptosis within 20 min of exposure. The rapidity of this response provides a constraint on its possible mechanism. In particular, it suggests that its regulation does not occur at the transcriptional level (see also Hensey and Gautier, 1998) .
Untreated control embryos begin to display a very low basal level of apoptosis, over the same developmental time window. In such untreated controls, no apoptotic cells can be detected before 7 h of development. After this time, a basal level of apoptosis becomes detectable in the deep and enveloping cell layers of the embryo, at a frequency which increases up to a maximum of ϳ1% by the end of gastrulation (9 -10 h postfertilization). Thus, we hypothesize that the apoptotic response to camptothecin is but one aspect of the acquisition of a general capability for apoptosis, which appears at the mid-gastrula stage of development (see Hensey and Gautier, 1998 , and Discussion).
Camptothecin-Induced Apoptosis Displays a Classical Phenotype
The term "apoptosis" refers to a stereotypic mode of cell death which is controlled by specific biochemical and genetic mechanisms (see White, 1996; Vaux and Strasser, 1996; Driscoll, 1996; Peter et al., 1997) . In mammalian cells, death by apoptosis has a phenotype comprising plasma membrane "blebbing," the proteolytic degradation of specific sets of nuclear and cytoplasmic proteins, the condensation of DNA-containing chromosome fragments at the periphery of the nucleus, the internucleosomal cleavage of genomic DNA, and a lack of dispersal of cell contents (Kerr et al., 1972 (Kerr et al., , 1995 Wyllie et al., 1984; White, 1996; Vaux and Strasser, 1996) . However, in some biological systems, programmed cell death occurs by mechanisms other than apoptosis and has a different phenotype (Schwartz et al., 1993) . The data which we present below suggest that the stereotypic cell death which the camptothecin-treated zebrafish embryo displays is due to bona fide apoptosis.
Nuclear Fragmentation and TUNEL Assay
Treatment of zebrafish embryos with 60 M camptothecin induces the "margination" and fragmentation of nuclei within cells of the deep and enveloping layers. This can be clearly observed under 1000ϫ magnification in flattened whole mounts, after staining with Hoechst 33258. Figure 2A displays a gallery of images of individual nuclei from the deep cell layer of an untreated control embryo. Figure 2B displays mitotic nuclei from the same control embryo. (From left to right, nuclei are shown in early prophase, late prophase, metaphase, and anaphase.) Figure  2C displays a gallery of images of individual nuclei from the deep cell layer of an embryo which has been treated with camptothecin. The images have been arranged in approximate order of increasing extent of nuclear margination and fragmentation. The apoptotic nuclei in Fig. 2C appear very different from the normal interphase nuclei of Fig. 2A and from the mitotic structures of Fig. 2B .
By a detailed analysis of the various images of this figure, we compute that the optical limit of resolution in our flattened whole mounts is ϳ500 Ϯ 100 nm. This is roughly 1 20 of the ϳ10-m diameter of an individual deep-layer nucleus and compares favorably to the Rayleigh limit of ϳ180 nm for blue light of wavelength ϭ 460 nm under a 100ϫ, NA 1.3 objective (Slayter and Slayter, 1992) . Thus, our detection system should be capable of accurately recording the phenotype of nuclear margination and fragmentation. We conclude that, in a camptothecin-treated zebrafish embryo, cells proceed along a stereotypic course of increasingly severe nuclear destruction, which does not occur in untreated control embryos. This phenotype is quite similar to the classical description of nuclear destruction which has been observed during apoptosis in mammalian cells (see, e.g., Wyllie et al., 1984) .
The TUNEL assay (Gavrieli et al., 1992; Grasl-Kraupp et al., 1995) utilizes TdT to add labeled deoxynucleotide residues to the 3Ј-OH termini of fragmented DNA strands within apoptotic nuclei. In mammalian cells, a positive signal in the TUNEL assay is generally accepted as evidence for nuclease-catalyzed DNA fragmentation during apoptosis. We applied the TUNEL assay to zebrafish embryos which had been treated with 60 M camptothecin over the 6-to 9-h developmental period. The results of this assay are shown in Fig. 3 . An untreated control embryo, when stained with Hoechst 33258, displays intact nuclei and mitotic figures, but no nuclear fragments (Fig. 3A ). In such a control, none of the nuclei or mitotic figures are TUNELpositive (Figs. 3B and 3C). In contrast, a camptothecintreated embryo displays many nuclear fragments, which are evident under staining with Hoechst 33258 (Fig. 3D ) and which also are positive in the TUNEL assay (Fig. 3E ).
Cell-Surface Alteration
A second aspect of the zebrafish embryo's response to camptothecin is a rapid and specific change in the morphology of the surface of affected deep-layer cells. This was revealed in experiments in which embryos were dissociated into single cells and then exposed to camptothecin. Figure 4 presents an analysis of typical images from a control cell (left) and from a cell that was treated with 60 M camptothecin from 6 to 8 h postfertilization (right). Figure 4A presents a pair of epifluorescence images which were obtained after staining with Hoechst 33258. A destruction of the nucleus is evident in the camptothecin-treated cell (right), but not in the control cell (left). Figure 4B presents the raw, unprocessed phase-contrast images of the surfaces of these two cells. Figure 4C presents a digital enhancement of the phase-contrast images from Fig. 4B . There is a clear difference between the two enhanced images. The surface of the untreated control cell (left) displays small, spheroidal dark regions ("blebs") which are each ϳ2.2 m wide. In contrast, the surface of the camptothecin-treated apoptotic cell (right) shows blebs which are fewer in number and which have larger widths (ϳ4.5 m each). (The width of a bleb is defined as Ϯ2 of a Gaussian fit of pixel intensity across a diameter line.) Figure 4D (left) presents a detailed quantitative analysis of one of the surface blebs from a camptothecin-treated cell. Figure 4D (right) presents the statistical distributions of the widths of the blebs on the surfaces of the control and camptothecin-treated cells. The two distributions clearly are quite different.
Our analysis of these (and other) phase-contrast images shows clearly that the camptothecin treatment induces a morphological change in the surface membrane of responsive deep-layer cells. This appears similar to the plasma membrane blebbing which is a hallmark of apoptosis in mammalian cells (Lazebnik et al., 1993; Kothakota et al., 1997; Rudel and Bokoch, 1997; Mills et al., 1998) . By carefully examining many phase-contrast photomicrographs of dissociated cells, at different times after camptothecin treatment, we conclude that plasma membrane blebbing occurs temporally before the fragmentation of the cell nuclei. The blebbing response cannot be clearly observed for individual cells within zebrafish flattened whole mounts, because the borders between adjacent cells are not easily visualized in situ.
DNA Fragmentation, as Revealed by Gel Electrophoresis
A third hallmark of classically defined apoptosis is the generation of chromatin or DNA fragments which can be At 9 h, the embryos were fixed and examined as flattened whole mounts. Successive images in (C) show progressive stages of fragmentation of individual cell nuclei from a single representative embryo, as revealed by staining with Hoechst 33258. All images were obtained with a 100ϫ NA 1.30 (oil immersion) objective. Scale bars, 10 m each. Spatial resolution in the (x,y) plane is estimated to be 500 Ϯ 100 nm. For comparison, the Rayleigh limit for blue light at ϭ 460 nm under an NA 1.3 objective is ϳ180 nm (Slayter and Slayter, 1992) . 
FIG. 4.
Camptothecin-induced apoptosis involves cell-surface blebbing and is cell autonomous. Blastulae were dissociated to individual cells and cultured in a growth chamber. At a time corresponding to early gastrula stage in untreated control embryos, 60 M camptothecin was added. Control cells from untreated blastulae were also maintained in a growth chamber. Periodically cells were fixed, stained with Hoechst 33258, and examined under both epifluorescence and phase-contrast microscopy using a 20ϫ (NA 0.5) objective. A representative control cell is shown on the left, and a representative camptothecin-treated cell is shown on the right. Scale bars, 10 m each. (A) Epifluorescence images of nuclei stained with Hoechst 33258. (B) Raw (8-bit gray scale) phase-contrast images. (C) Digital enhancement of (B). (D) Statistical analysis of spheroidal dark blebs in the enhanced images in (C). Left: digitized line profile across the diameter of a cell-surface bleb from a camptothecin-treated cell ( . . . ) and Gaussian least-squares fit (--). For a Gaussian curve, 95.5% of the integrated pixel intensity lies within Ϯ2 of the mean. The "width" of a bleb is defined as Ϯ2 in such a Gaussian fit. Right: cumulative distribution of widths of dark surface blebs, for untreated control cell (E) and camptothecin-treated cell (F). For the untreated cell, the mean bleb width was Ϸ2.2 m. For the camptothecin-treated cell, the mean bleb width was Ϸ4.6 m.
FIG. 3.
Camptothecin-induced DNA fragmentation as revealed by TUNEL assay. Embryos were exposed to 60 M camptothecin at 6 h postfertilization. They were then assayed by TUNEL, counterstained with Hoechst 33258, and examined in the flattened whole-mount format. A positive TUNEL assay result, indicating the presence of DNA fragments labeled with digoxygenin-dUTP, was rendered visible with a Texas red-conjugated anti(digoxygenin) antibody. visualized by gel electrophoresis (Wyllie et al., 1984) . When zebrafish embryos are treated with 60 M camptothecin starting at 6 h postfertilization, then at 9.5-10 h a nucleosomal ladder is produced, which can be detected by electrophoresis on a nondenaturing agarose gel. The 9.5-to 10-h time point corresponds to late-gastrula stage in untreated controls. Figure 5A presents a phosphorimage of such a gel, which had been blotted to a nylon membrane and then hybridized with a 32 P-labeled probe made from zebrafish total genomic DNA. Figure 5B presents the quantitation of the phosphorimage from Fig. 5A . The production of a nucleosomal ladder is consistent with the classical definition of apoptosis.
Significantly, when zebrafish embryos from the above experiment are examined earlier (between 7 and 9 h of development), then little or no nucleosomal ladder is observed, even though ϳ15% of the nuclei have become "marginated" or fragmented at the cytological level (compare Figs. 5A and 5B with Figs. 1C and 2C) . Thus the fragmentation of genomic DNA during camptothecininduced apoptosis in the zebrafish embryo has a complex profile in developmental time. It displays two different patterns, before and after the 10-h time point. It may be significant that the 10-h time point coincides with entry into the segmentation stage of development (see Discussion).
Cell Autonomy and Timing of CamptothecinInduced Apoptosis
The experiment of Fig. 4 also provides a test of whether camptothecin-induced apoptosis is cell autonomous. The property of cell autonomy is predicted for a checkpoint pathway which monitors the integrity of an intracellular process such as DNA replication or the integrity of an intracellular structure such as the genome. In the experiment of Fig. 4 , a significant fraction of the population of dissociated gastrula-stage cells became apoptotic, in response to treatment with 60 M camptothecin. In contrast, over the same time period, the population of untreated control cells, which were produced by embryo dissociation without camptothecin treatment, remained viable and mostly nonapoptotic (data not shown). Thus, camptothecin-induced apoptosis appears to be cell autonomous.
No apoptosis can be observed before 7 h of development, either in dissociated cells or in the intact zebrafish embryo, in response to an earlier treatment with camptothecin. The 7 h time point corresponds exactly to the time when we first can detect apoptosis (at a frequency of Յ1%) in untreated control embryos. It also corresponds to the time when fertilized but uncleaved eggs begin to spontaneously die (see Fig. 9 below) . This supports our hypothesis that a timing mechanism controls the acquisition of a general capability for apoptosis, at the mid-gastrula stage (around 7 h postfertilization). A similar hypothesis recently has been proposed for the activation of the capability to undergo apoptosis in the Xenopus embryo (Sible et al., 1997; Stack and Newport, 1997; Gautier, 1997, 1998; Anderson et al., 1997) .
Dynamic Behavior of Cell Nuclei between the Time of Camptothecin Treatment and the Time of Entry into Apoptosis
We next studied the behavior of nuclei from the embryo's three cell layers, between the time of exposure to camptothecin and the time of entry into apoptosis. Over this period, the nuclei are prevented from entering mitosis (Fig.  1B) . We used Hoechst 33258 to stain for all nuclei and a Br-dU-incorporation assay to detect nuclei which were actively synthesizing DNA. This allowed us to establish two subtle points about the dynamic behavior of the (nonmitotic) nuclei in a camptothecin-treated embryo.
(1) An increase in nuclear volume occurs before the nuclei enter apoptosis. (2) The nuclei synthesize new DNA before they enter apoptosis.
Nuclear Volume Increase
Zebrafish embryos were treated with 60 M camptothecin at various times during development, beginning at late-blastula stage (4 h postfertilization). The embryos were then converted into flattened whole mounts (as in Fig. 1A ) and examined by either conventional or confocal epifluorescence microscopy. Treatment with camptothecin immediately caused the mitotic index of the deep-layer cells to drop to zero (Fig. 1B and Ikegami et al., 1997a) . Eventually these cells entered apoptosis (Fig. 1C) . However, between the time of treatment and the time of apoptosis (a period of ϳ4 h), another response was observed: the deep-layer cells gradually increased in nuclear volume, on average by a factor of 3 (Fig. 6A) . Some of the nuclei became extremely large, as shown by the upper tail of the cumulative distribution of volumes, in the 4-h curve in this figure.
Br-dU Incorporation
We next established that the increase in nuclear volume was correlated with a continued synthesis of DNA. Embryos were treated with 60 M camptothecin beginning at 6 h postfertilization. One-half hour later, Br-dU was added to 10 mM. At 9 h postfertilization, they were fixed and stained immunohistochemically for Br-dU incorporation into the genomic DNA. Finally, the embryos were converted into flattened whole mounts and examined. Figure  6B The images in Figs. 6B, 6D, and 6E were obtained with conventional epifluorescence microscopy on flattened whole mounts. It appeared that, in all three cell layers of a camptothecin-treated embryo, DNA synthesis occurred within individual nuclei, in a punctate fashion. Before considering the possible significance of this finding, we wanted to make sure that our observations (which had been obtained with conventional epifluorescence microscopy on flattened whole mounts) were of sufficient optical resolution that punctate foci of DNA synthesis within individual nuclei could accurately be observed. Therefore, we also examined a flattened whole mount by confocal fluorescence microscopy and computed the optical limit of resolution in both the conventional and the confocal images. Figure 6C shows an image of a single deep-layer nucleus, obtained as a composite of eight successive optical slices from a confocal fluorescence microscope. The confocal image demonstrates essentially the same result as the conventional epifluorescence images of individual deeplayer nuclei in the separate panels of Fig. 6B .
In Figs. 6F and 6G we compute the optical resolution of the conventional and confocal images, respectively. The resolution of an image was computed by finding two barely separated points of fluorescence, drawing a line profile across them, and fitting the pixel intensities along the line profile to a pair of Gaussian functions (representing two point sources of light). We find that the optical resolution limit is Ͻ500 nm in both the conventional image (Fig. 6F ) and the confocal image (Fig. 6G ). This compares favorably to the Rayleigh limit of ϳ230 nm for orange light of wavelength ϭ 590 nm, under an NA 1.3 microscope objective (Slayter and Slayter, 1992) . Thus, our imaging capability in flattened whole mounts appears to be high enough to accurately detect foci of DNA synthesis within individual cell nuclei, by means of Br-dU labeling, using conventional fluorescence microscopy.
We conclude that, after camptothecin treatment but before apoptosis, in all three cell layers of the gastrula-stage zebrafish embryo, DNA synthesis occurs throughout the entire volume of many or most nuclei, but in discrete, spatially localized foci. In accordance with Manders et al. (1996) , we hypothesize that these foci consist of discrete DNA synthesis domains.
Our experiment cannot provide information about which DNA polymerase is incorporating the Br-dU or about whether the incorporation is due to replicative synthesis or repair synthesis. Br-dU incorporation could be an indicator of replicative synthesis by DNA polymerase ␣. Alternatively, it could be an indicator of repair synthesis by a variety of other DNA polymerases. It is unknown how the functions of replicative and repair synthesis are partitioned between the different DNA polymerases in the early zebrafish embryo (see Wood and Shivji, 1997) .
Finally, we note that the YSL nuclei display two novel and interesting behaviors. (1) A lesser amount of Br-dU is incorporated into the YSL nuclei, compared to the EVL and deep-layer nuclei. In addition, the DNA synthesis domains are more widely separated from each other in the YSL nuclei than in the EVL or deep-layer nuclei. This may indicate a lower number of DNA synthesis domains, or a lower rate of DNA synthesis per domain, in the YSL. (2) Although the camptothecin-treated YSL nuclei continue to synthesize DNA, they never exhibit a FIG. 5. Camptothecin-induced apoptosis produces a nucleosomal ladder. Embryos were treated with 60 M camptothecin beginning at 6 h postfertilization. Then, at half-hour intervals between 7 and 12 h, subsets of the embryos were homogenized in high-EDTA buffer. Genomic DNA was extracted, run on a 1% agarose gel in TBE buffer, and transferred to a nylon membrane. After UV treatment, the membrane was hybridized with a randomly primed total zebrafish genomic DNA probe. Untreated control embryos of 7 and 12 h age (7.0C and 12.0C, respectively) were also processed in this way. fragmentation phenotype under Hoechst 33258 staining or a positive readout in the TUNEL assay (data not shown). Thus, by our assays, camptothecin does not appear to induce apoptosis in the YSL.
Exposure to DNA Replication Blockers before MBT
In Xenopus, apoptosis will be produced at gastrula stage, if an embryo is treated before MBT with cycloheximide (Hensey and Gautier, 1997; Sible et al., 1997) , ␥-irradiation (Hensey and Gautier, 1997; Anderson et al., 1997) , hydroxyurea (Stack and Newport, 1997) , emetine (Sible et al., 1997) , or ␣-amanitin (Sible et al., 1997) . Surprisingly, it has been reported that two of these agents (␥-irradiation, hydroxyurea) will produce gastrula-stage apoptosis if applied before MBT, but not if applied after MBT (Hensey and Gautier, 1997; Anderson et al., 1997; Stack and Newport, 1997) .
These findings in Xenopus led us to ask two questions.
(1) If zebrafish embryos are transiently pulsed with camptothecin (or some other DNA replication blocker) before MBT, then will their cells undergo apoptosis in gastrula stage? (2) Will certain agents induce gastrula-stage apoptosis in the zebrafish embryo if applied before MBT, but not if applied after MBT? To answer these questions, we exposed zebrafish embryos to three agents which block DNA replication by different mechanisms. One agent (camptothecin) acts irreversibly, while the other two agents (aphidicolin, hydroxyurea) act reversibly. The agents were applied at various developmental stages, and exposure was either transient or continuous. We found that the zebrafish embryo's response to an early (pre-MBT) treatment with any of these agents is the same: sudden embryo death at 10 Ϯ 1.5 h. Nonetheless, there were a number of minor differences, depending on the agent's mode of action (irreversible or reversible) and on the time-course of treatment. We now summarize these experiments.
Treatment with Camptothecin
Zebrafish embryos were given either a transient or a chronic exposure to 1, 10, or 60 M camptothecin in cleavage, blastula, or early gastrula stage. At the gross level, the nature of the embryonic response was essentially the same for nearly all treatments: the embryos died at a time corresponding to late-gastrula stage in controls. (Death was defined to occur when all of an embryo's cells turned opaque white and began to lyse.) However, treatmentspecific differences were observed at the level of individual nuclei in Hoechst-stained flattened whole mounts.
Treatment during early cleavage. We treated embryos with a transient pulse of 1, 10, or 60 M camptothecin over the 4-to 8-cell stage or the 8-to 16-cell stage. Such embryos remained alive until 10 Ϯ 1.5 h postfertilization, when they suddenly died (Fig. 7A) . A microscopic examination of flattened whole mounts revealed that, at 9 h, a dying embryo contained only ϳ100 nuclei, plus many additional enucleate cells. All nuclei in such an embryo were either grossly deformed or apoptotic. Many of the grossly deformed nuclei displayed Hoechst-positive bridges to each other, suggesting the formation of multipolar spindles during passage through mitosis (Fig. 7B) . Apoptotic nuclei could be identified also, by their distinctive marginated and fragmented appearance (Fig. 7C) . In contrast, nuclei from FIG. 6. Dynamic behavior of nuclei in camptothecin-treated embryos, before the apoptotic phenotype is displayed. (A) Cumulative distribution of volumes of deep-layer nuclei. Embryos were treated with 60 M camptothecin, beginning at 6 h postfertilization and continuing for the next 1, 2, 3, or 4 h. After treatment the embryos were fixed, stained with Hoechst 33258, converted into flattened whole mounts, and examined under a 100ϫ (NA 1.30) oil immersion objective. The volumes of 150 deep-layer nuclei per embryo were estimated. The cumulative distribution of nuclear volumes is plotted for the different camptothecin treatment lengths and for untreated controls. (B) DNA synthesis in deep-layer nuclei. Embryos were exposed to 10 mM Br-dU and 60 M camptothecin for 3 h, beginning at 6 h postfertilization. They were then processed for anti(Br-dU) immunohistochemistry and examined as flattened whole mounts. A gallery of photomicrographs of individual deep-layer nuclei, obtained with conventional epifluorescence microscopy, from a representative embryo is shown. Scale bar, 10 m. (C) Confocal image of a single deep-layer nucleus from the camptothecin-treated embryo of (B). This image was collected on a Leica TCS4D confocal microscope, using an Omnichrome krypton-argon ion laser illumination source and a 100ϫ (NA 1.4) oil immersion plan-apochromat objective. The 568-nm laser line was used for excitation, and a detector wavelength of 590 nm was selected by means of a dichroic filter. A series of confocal slices, each 20 nm thick and spaced 1 m apart, was collected at 512 ϫ 512-pixel resolution, with 8ϫ line averaging. The image shown is a superimposition of eight consecutive slices. Scale bar, 3.3 m. (D) DNA synthesis in EVL nuclei. A gallery of photomicrographs of individual EVL nuclei from a representative single embryo, under anti(Br-dU) staining and conventional epifluorescence microscopy, is shown. Scale bar, 10 m. (E) DNA synthesis in YSL nuclei. A gallery of photomicrographs of individual YSL nuclei from a single representative embryo, under anti(Br-dU) staining and conventional epifluorescence microscopy, is shown. Scale bar, 10 m. (F and G) Limit of optical resolution for images obtained from a flattened whole mount, using either conventional epifluorescence microscopy (F) or confocal fluorescence microscopy (G). In either case, a line profile was drawn across two neighboring (but separate) points of fluorescent light. The resultant plot of pixel intensity versus position along the line profile was fit to a pair of Gaussian functions, representing emission from a pair of point sources. Spacing between peak centers is 530 nm for the conventional epifluorescence image in F and 480 nm for confocal image in G. For comparison, the Rayleigh limit for 590-nm orange light under an NA 1.3 objective is ϳ230 nm (Slayter and Slayter, 1992). untreated control embryos at 9 h appeared normal under Hoechst staining (Fig. 7D) .
Thus, when embryos are exposed to camptothecin at the early cleavage stage, all of their nuclei quickly accumulate a lethal amount of damage, which prevents more than two or three additional rounds of nuclear division. Nonetheless, the embryo as a whole remains alive until 10 Ϯ 1.5 h postfertilization, when it suddenly turns opaque white, begins to lyse, and thereby dies. The time course for this mode of embryo death was parallel to the time course by which the apoptotic capability is acquired at the cellular level (Fig. 1C) . The 10 Ϯ 1.5-h interval corresponds to the transition between gastrula and segmentation stages, in untreated controls.
Treatment during the blastula stage. When embryos were treated with 1, 10, or 60 M camptothecin over the early blastula stage (2-3 h age), they remained alive until 10 Ϯ 1.5 h of age and then suddenly died (Fig. 7A) . The death curves superimpose exactly upon those for camptothecin given at the early cleavage stage. When the dying embryos from an early blastula camptothecin treatment are examined at 9 h, a complicated syndrome of defects is found. The defects include mitotic figures with disordered and broken chromosomes (Fig. 7E) , micronuclei (Fig. 7F) , and dumbbelllike pairs of connected interphase nuclei (Fig. 7G) . Significantly, we also observe nuclei which display a marginated and fragmented appearance, indicating apoptosis (Fig. 7H) . However, many normal nuclei are also found, and in general, the phenotype is less severe than for embryos treated at the 8-to 16-cell stage. We hypothesize that, around MBT, a checkpoint mechanism becomes activated, which limits the extent of nuclear damage which is induced by camptothecin (see Ikegami et al., 1997a) .
Treatment at and beyond gastrula stage. When a high (60 M) dose of camptothecin is given at the early gastrula stage, then the treated embryos remain alive until 10 Ϯ 1.5 h of age, when they die (Fig. 7A) . However, when a low (1 M) dose of camptothecin is given, then the treated embryos remain alive beyond the 10 Ϯ 1.5-h time point (see, for example, the closed triangles (OE) curve in Fig. 7A ). The cells in such embryos exhibit an arrest of cell proliferation (Fig. 1B) and begin to undergo apoptosis (Fig. 1C) . Such embryos eventually die at a time corresponding to midsegmentation stage in controls (not shown). If a camptothecin treatment is given late in gastrula stage, or in segmentation stage, then fewer of the embryo's cells become apoptotic, and the embryo lives longer before eventually dying (data not shown).
Summary. Gastrula stage (6 -10 h postfertilization) defines a critical phase in zebrafish development, with respect to the response to camptothecin. Before gastrula stage, even a transient pulse of camptothecin will inevitably produce embryo death at 10 Ϯ 1.5 h. This type of death is tightly correlated with a large amount of apoptosis at the cellular level. In contrast, when applied during gastrula stage, camptothecin will produce an arrest of proliferation of all cells, followed by apoptosis in some fraction of cells. However, in some cases, the embryo can survive well beyond 10 Ϯ 1.5 h. We hypothesize that, in such an embryo, increasing numbers of terminally differentiated, nonmitotic cells have acquired a much-reduced tendency for camptothecininduced apoptosis. If a sufficiently high fraction of embryonic cells are postmitotic at the time of treatment, then the embryo can remain alive for many hours (see Discussion).
Aphidicolin or Hydroxyurea Treatment
We also conducted experiments in which embryos were exposed to aphidicolin or hydroxyurea. These agents inhibit DNA replication in a reversible manner. Aphidicolin directly blocks the function of DNA polymerase ␣ (the main replicative polymerase) by competitive inhibition of the binding of dNTPs (Sheaff et al., 1991) . Hydroxyurea blocks the function of ribonucleotide reductase, thus preventing the conversion of rNTPs into dNTPs, which are the substrates for DNA polymerase ␣ (see Kornberg, 1980) . Hydroxyurea was employed by Stack and Newport (1997) and Gallery of nuclei with multipolar spindles, observed at 9 h in embryos which had been treated over the 8-to 16-cell stage with 60 M camptothecin. (C) Gallery of apoptotic nuclei, observed at 9 h in embryos which had been treated over the 8-to 16-cell stage with 60 M camptothecin. (D) Gallery of normal nuclei from untreated control embryo, examined at 9 h. (E) Defective mitotic figures, observed at 9 h in embryos which had been treated at early blastula stage with 1 M camptothecin. (F) Micronuclei (arrowheads), observed at 9 h in embryos which had been treated at early blastula stage with 1 M camptothecin. (G) Stretched nuclei, observe at 9 h in embryos which had been treated at early blastula stage with 1 M camptothecin. Two extremely fine stretched fibers, emanating from a single nucleus, are indicated by arrowheads. (H) Apoptotic nuclei, observed at 9 h in embryos which had been treated at early blastula stage with 1 M camptothecin. In B-H, embryos were examined as flattened whole mounts under a 100ϫ (NA 1.30) oil-immersion objective. Scale bars, 10 m each. Hensey and Gautier (1997) to induce apoptosis in early Xenopus embryos.
Treatment at 4-to 8-cell stage. When we treat zebrafish embryos chronically, starting at the 4-to 8-cell stage, with 25 g/ml aphidicolin or with 130 mM hydroxyurea, then all of the treated embryos die upon reaching 8 -10 h of age (Figs. 8A and 8B, respectively) . The dying embryos contain many apoptotic cells (Figs. 8E and 8F) . The time course of aphidicolin-or hydroxyurea-induced embryo death is exactly the same as the time course of camptothecin-induced embryo death (Fig. 7A) . The 8-to 10-h period corresponds to lategastrula stage in untreated controls. Xenopus embryos which received a pre-MBT treatment with hydroxyurea were found to die by apoptosis at a comparable stage of development (Stack and Newport, 1997; Hensey and Gautier, 1997) .
Treatments between 8-cell stage and MBT. If the aphidicolin or hydroxyurea treatment is started later in time (between the 8-cell stage and the MBT), then most of the embryos survive beyond 8 -10 h of age. Cells in these embryos continue to proliferate and to produce many new daughter nuclei (Fig. 8C ). Such embryos, although not fated to die at midgastrula, nonetheless contain significant numbers of apoptotic nuclei (Fig. 8D ). This behavior is profoundly different from the zebrafish embryo's response to camptothecin over this same period. Camptothecin produces both an efficient arrest of cell proliferation (Fig. 1B) and the inevitable death of the embryos (Fig. 7A) .
Post-MBT treatments. A post-MBT treatment with aphidicolin fails to produce cell-proliferation arrest, apoptosis, or embryo death (not shown; see Ikegami et al., 1997a, for details). Treatment with hydroxyurea after MBT produces a high prevalence of unusual nuclei with central Hoechst-excluding depressions (Fig. 8G) . It also produces apoptosis in some fraction of an embryo's cells (Fig. 8D,  right; Fig. 8H ). However, cells continue to proliferate, and the embryo remains alive. In untreated controls, apoptotic nuclei and nuclei with Hoechst-excluding central regions are very rare. These observations appear to differ from what has been reported for Xenopus. In the frog embryo, a pre-MBT dose of hydroxyurea will produce apoptosis at gastrula stage, but a post-MBT dose of hydroxyurea will not (Stack and Newport, 1997; Hensey and Gautier, 1997) .
Apoptosis in Response to DNA Blockers May Be One Aspect of a More General Capability for Stressor Damage-Induced Apoptosis
The preceding experiments reveal that, for three DNA replication blockers with very different mechanisms, an early treatment (before MBT) will alter the embryo in such a way that approximately at mid-gastrula stage, it will suddenly die by apoptosis (Figs. 7 and 8) . The time course of this apoptotic response exactly parallels the appearance of a low level (Ͻ1%) of spontaneous apoptosis in untreated control embryos (data not shown). It also parallels the time course by which fertilized but uncleavable eggs will spontaneously die (Fig. 9) . We hypothesize that the capability to undergo stress-or damage-induced apoptosis in the zebrafish embryo is acquired under the control of a maternally   FIG. 8 . Effects of early treatment with aphidicolin or hydroxyurea. (A) Survival curves for aphidicolin treatments. Sets of replicate embryos (N ϭ 22-25) either were pulsed with aphidicolin and then transferred to water or were left in aphidicolin. The embryos were checked periodically for survival. Treatments: (F) 25 g/ml chronic exposure, starting at 4-to 8-cell stage; (ᮀ) 0.5 g/ml 1-h pulse over the 8-to 16-cell stage; (‚) 5 g/ml 1-h pulse over the 8-to 16-cell stage; (s) 25 g/ml 1-h pulse over the 8-to 16-cell stage; (OE) 25 g/ml chronic exposure, starting at 16-to 32-cell stage; (E) 25 g/ml chronic exposure, starting at dome-sphere stage. The untreated control embryos display 100% survival through 12 h. (B) Survival curves for hydroxyurea treatments. Sets of replicate embryos either were pulsed with hydroxyurea and then transferred to water or were left in hydroxyurea. The embryos were checked periodically for survival. Treatments: (‚) 130 mM 1-h pulse over the 4-to 8-cell stage; (F) 130 mM chronic exposure, starting at the 4-to 8-cell stage; (s) 0.1 mM chronic exposure, starting at the 4-to 8-cell stage; (OE) 10 mM chronic exposure, starting at the 4-to 8-cell stage; (ᮀ) 30 mM chronic exposure, starting at the 4-to 8-cell stage; (s) 30 mM chronic exposure, starting at late-blastula stage; (OE) 130 mM chronic exposure, starting at late-blastula stage; (E) untreated controls (100% survival over 12 h). (C) Inhibition of cell replication by aphidicolin and hydroxyurea. Left: number of nuclei per embryo, assayed at 8 h, for untreated controls (CON), for embryos treated chronically with 25 g/ml aphidicolin starting at the 4-to 8-cell stage (A25), and for embryos treated transiently with 130 mM hydroxyurea over the 4-to 8-cell stage (H130). Right: number of nuclei per embryo, assayed at 11 h, for untreated controls (CON), for embryos treated chronically with 25 g/ml aphidicolin starting at late-blastula stage (A25), and for embryos treated transiently with 130 mM hydroxyurea starting at late-blastula stage (H130). (D) Induction of apoptosis by aphidicolin and hydroxyurea. Left: percentage apoptotic nuclei assayed at 8 h, for untreated controls (CON), for embryos treated chronically with 25 g/ml aphidicolin starting at the 4-to 8-cell stage (A25), and for embryos treated transiently with 130 mM hydroxyurea over the 4-to 8-cell stage (H130). Right: percentage apoptotic nuclei assayed at 11 h, for untreated controls (CON), for embryos treated chronically with 25 g/ml aphidicolin starting at the late-blastula stage (A25), and for embryos treated transiently with 130 mM hydroxyurea over the late-blastula stage (H130). (E) Apoptotic nuclei, in embryo treated chronically with 25 g/ml aphidicolin beginning at 4-to 8-cell stage and then examined at 9 h. (F) Apoptotic nuclei, in embryo treated chronically with 130 mM hydroxyurea beginning at 4-to 8-cell stage and then examined at 9 h. (G) High frequency of nuclei that display Hoechst-excluding central regions. These were produced by chronic treatment with 30 mM hydroxyurea beginning at late-blastula stage. Examination at 9 h. (H) Apoptotic nuclei, in embryo treated chronically with 130 mM hydroxyurea beginning at late-blastula stage. Examination at 9 h. In (E-H), embryos were examined as flattened whole mounts, using a 100ϫ (NA 1.30) objective. Scale bars, 10 m each. encoded timer. This same hypothesis has also recently been proposed for Xenopus (Stack and Newport, 1997) .
Emergence of Lineage-and Tissue-Specific Differences in the Response to Camptothecin
Gastrula Stage
Around cell cycles 10 -12, the zebrafish embryo differentiates into three mitotic domains-the EVL (enveloping epithelial monolayer), the deep cell layer, and the YSL (yolk syncytial layer) (Kane et al., 1992) . We have asked whether, in an intact embryo, these three mitotic domains display different tendencies to undergo apoptosis, in response to treatment with camptothecin. We have also asked whether any of these mitotic domains contains subpopulations of cells which exhibit unusually high or low levels of apoptosis. The flattened whole-mount assay ) is able to preserve spatial information in the z dimension. Thus, we may clearly distinguish the behavior of all cell nuclei in the YSL, the deep cell layer, and the EVL layer without embedding or sectioning.
Embryos were treated with 60 M camptothecin over the 6-to 9-h developmental period. They were then assayed for nuclear fragmentation at 9 h postfertilization, which is the time when untreated embryos reach late gastrula stage. Cells in the enveloping and deep cell layers were found to display a capability for apoptosis. In contrast, the YSL nuclei showed no tendency to undergo apoptosis.
Within the EVL or deep layer, we found no significant variation in the tendency for apoptosis, as a function of either z-axial position or radial position. However, it remains possible that certain restricted portions of the fate map, or certain cell lineages within the deep layer, may display a subtle bias which we failed to detect. It may be necessary to use lineage-specific probes, in conjunction with the flattened whole-mount assay, to fully address this possibility.
Segmentation Stage
To determine if any lineage-or tissue-specific differences in apoptosis appeared around the entry into segmentation stage, we compared the effects of a 3-h pulse of 60 M camptothecin, initiated 5, 6, 7, 8, 9, or 10 h postfertilization. Two different "compartments," the embryo proper and the epithelial covering of the yolk, could be compared with high precision. Replicate fields were assayed within embryos that had been prepared as flattened whole mounts, and counts were made of the numbers of nonapoptotic and apoptotic nuclei per microscopic field. We observe an approximately 10-fold greater frequency of apoptotic nuclei per microscopic field for the embryo proper, compared to the epithelial covering of the yolk (data not shown).
The Caspase Inhibitor Ac-YVAD-CHO Will Block Camptothecin-Induced Apoptosis in the Zebrafish Embryo
In Caenorhabditis elegans and also in mammalian cells, the "degradation" phase of apoptosis displays an absolute requirement for one or more caspases (cysteinyl aspartatespecific proteinases) (Cohen, 1997) . Recent studies also suggest this may be true in the Xenopus embryo (Stack and Newport, 1997) . Therefore, we wanted to determine if camptothecin-induced apoptosis in the zebrafish embryo could be blocked by caspase inhibitors.
FIG. 9.
Precisely timed spontaneous death of fertilized but uncleaved zebrafish eggs. In two clutches of embryos, we found significant numbers of eggs which were fertilized but unable to cleave (N ϭ 6 and N ϭ 19 for the two experiments). These eggs were maintained in water and examined periodically. From analysis of molecular phylogeny and from substrate specificity determinations, it has been possible to sort the mammalian caspases into three classes Thornberry et al., 1997) . The caspase inhibitor Ac-YVAD-CHO is effective against human caspases-1, -4, and possibly -5, which fall into specificity group 1 . For this inhibitor, the K i for human caspase-1 is 6 nM, and the K i for human caspase-4 is 14 nM (Margolin et al., 1997) . The caspase inhibitor Ac-DEVD-CHO is effective against human caspases-3, -7, and possibly -2, which fall into specificity group 2 . For this inhibitor, the K i for human caspase-3 is 0.5 nM, and the K i for human caspase-7 is 35 nM (Margolin et al., 1997) . However, Ac-DEVD-CHO is also very effective at inhibiting human caspase-1 (of specificity group 1), with a K i of 15 nM (Margolin et al., 1997) .
Although the substrate specificities of Ac-YVAD-CHO and Ac-DEVD-CHO are not absolute, they nonetheless appear great enough to produce useful information in experiments with zebrafish embryos. Accordingly, we treated zebrafish embryos with these inhibitors, beginning at 5.5 h postfertilization. We then exposed the embryos to 60 M camptothecin, beginning at 6 h. Finally, we assayed for apoptosis at 10 h. Results are summarized in Fig. 10 . Figure  10A presents the entire set of experimental data, while Fig.  10B presents the data for the early time points, on an expanded scale. Two conclusions may be drawn from a careful analysis of this figure.
(1) Embryos which have been pretreated with Ac-DEVD-CHO and then exposed to camptothecin show essentially the same apoptotic profile as embryos which have received only the camptothecin treatment. This appears to rule out the participation of caspase-1, -3, and -7, and possibly -2 in the camptothecin-induced apoptotic response, over the period of 7-10 h postfertilization. (We know that Ac-DEVD-CHO is able to enter the cells of the zebrafish embryo, because it is able to block a different apoptotic response, which is induced by dissociating zebrafish embryos into cytokine-depleted medium; R. Ikegami and T. D. Yager, manuscript in preparation.) (2) In contrast, pretreatment of embryos with Ac-YVAD-CHO produces a significant block of camptothecin-induced apoptosis (Fig. 10A, open triangles) . This result, in combination with (1) above, implicates caspase-4, and possibly caspase-5, in camptothecin-induced apoptosis in the zebrafish embryo.
DISCUSSION
Rationale and Experimental Design
We have shown that the zebrafish embryo possesses a cell-autonomous mechanism which can trigger apoptosis in response to a DNA replication block. The mechanism becomes active at midgastrula stage and produces apoptosis in response to hydroxyurea, aphidicolin, or camptothecin treatment. Although these three agents block DNA replication by different molecular mechanisms, they all produce essentially the same result in our system-sudden death of embryos at 10 Ϯ 1.5 h postfertilization.
Most of our experiments used camptothecin, which is a specific inhibitor of topoisomerase I. Since topoisomerase I is an integral component of the DNA replication apparatus (Applegren et al., 1995; Simbulan-Rosenthal et al., 1996) , the response to camptothecin might involve the direct detection of a block to DNA replication. However, since camptothecin acts by irreversibly trapping a nicked-DNA transition state (Hsiang et al., 1985; Svejstrup et al., 1991; Redinbo et al., 1998) , the mechanism might instead be responding to DNA strand breaks. In mammalian cells, DNA strand breaks are extremely potent inducers of both cell-cycle arrest (Di Leonardo et al., 1994; Linke et al., 1997) and apoptosis (Enoch and Norbury, 1995; Kastan et al., 1995; Morgan and Kastan, 1997) . In any event, the relatively specific mode of action of camptothecin ensures that only one or a few checkpoint pathways are being probed.
Phenotype of Camptothecin-Induced Apoptosis
At a specific time during gastrulation, the zebrafish embryo acquires the capability to undergo apoptosis, in response to treatment with camptothecin (Fig. 1C) . This occurs distinctly later than the time when camptothecin first is able to induce an arrest of cell proliferation (compare Fig. 1B) . Upon treating gastrula-stage zebrafish embryos with camptothecin, cells of the deep and enveloping layers display four classical hallmarks of apoptosis: a stereotypic fragmentation of nuclei (Fig. 2) ; a positive readout in the TUNEL assay (Fig. 3) ; a pronounced blebbing of the plasma membrane (Fig. 4) ; and the production of a nucleosome ladder, which can be visualized by gel electrophoresis (Fig.  5) .
Camptothecin-induced apoptosis in the gastrula-stage zebrafish embryo has yet another distinguishing feature, which is a requirement for one or more caspases. The peptide inhibitor Ac-YVAD-CHO, which is specific for the group 1 caspases (caspases-1, -4 and possibly -5), efficiently blocks camptothecin-induced apoptosis, as monitored by the nuclear fragmentation phenotype in the flattened whole-mount assay. However, there is no significant inhibition by Ac-DEVD-CHO, which is specific for the group 2 caspases (caspases-2, -3, -7) and for caspase-1. These results suggest that caspase-4 or caspase-5 is required for camptothecin-induced apoptosis in the zebrafish embryo.
It is noteworthy that we do not detect the production of very large DNA fragments, with sizes in the 300 -1000 kb range, during camptothecin-induced apoptosis (examination by field-inversion gel electrophoresis; data not shown). The generation of DNA fragments in this size range is a hallmark of apoptosis in mammalian cells (Oberhammer et al., 1993; Sun and Cohen, 1994; Walker et al., 1994; Lagarkova et al., 1995) . It also is noteworthy that we observe the generation of a nucleosomal ladder only after 9.5 h of development (Fig. 5) . No nucleosomal ladder is observed before this time, even though an earlier camptothecin treatment produces the phenotype of nuclear fragmentation, as observed by Hoechst 33258 staining and the TUNEL assay (Figs. 1, 2, and 3) . We offer two alternative hypotheses to explain why the nucleosomal ladder can be observed only after 9.5 h.
(1) The nature of the developmental control over apoptosis might change around 9.5 h postfertilization. We note that 9.5-10 h of development corresponds to the end of gastrulation and the start of segmentation. This is a major developmental milestone in the zebrafish and, indeed, in all vertebrates.
(2) There might be two steps in genome fragmentation: a fast, infrequently acting process that cuts the genomic DNA in ϳ100 locations to generate large nuclear fragments which can be observed cytologically and a slower, much more extensive cleavage between nucleosomes, cutting the genomic DNA in ϳ10 7 places to produce the oligonucleosome ladder. (We estimate that a limited digest should contain ϳ10 7 cuts, by noting that a dinucleosome contains, on average, 360 bp of DNA and that the zebrafish genome contains 3.4 ϫ 10 9 bp of diploid DNA; Figure 5 and Hinegardner and Rosen, 1972.) A substantial lag phase in the generation of a nucleosomal ladder would be predicted if the production of a nucleosomal ladder depended on the activation of a caspase (Liu et al., 1997; Sakahira et al., 1998; Enari et al., 1998; Janicke et al., 1998; Halenbeck et al., 1998) and if such a caspase were activated in an autocatalytic fashion (reviewed by Cohen, 1997) .
The Capability for Apoptosis First Appears at Midgastrula Stage
The zebrafish embryo first becomes capable of camptothecin-induced apoptosis approximately at midgastrula stage, which falls ϳ7 h post-fertilization (Fig. 1) . At exactly the same time, the zebrafish embryo begins to show apoptosis as a response to the spindle-blocking agent nocodazole (Ikegami et al., 1997b) . In addition, fertilized but uncleavable zebrafish eggs spontaneously begin to die around 7 h (Fig. 9) . Finally, in untreated control embryos, a basal level of apoptosis can first be observed at ϳ7 h (data not shown). The coincident timing of all these events suggests to us that a general capability for apoptosis may become activated in the zebrafish embryo at midgastrula stage. The capability for apoptosis is acquired at a distinctly later time in development than is the capability for arrest of cell proliferation (Fig. 1B and Ikegami et al., 1997a,b) .
The capability to undergo apoptosis also is acquired much later in development than the general activation of zygotic transcription, which occurs at ϳ4 h postfertilization during MBT (Kane and Kimmel, 1993) . It seems reasonable to hypothesize that the embryo acquires a general capability for apoptosis as a consequence of passage through the maternal-to-zygotic transition (MZT). The MZT is defined by the depletion or degradation of maternal determinants (RNAs and proteins) and their replacement by zygotic determinants (Kane et al., 1996) . A similar hypoth-esis (that the capability for apoptosis is controlled by degradation of a maternal inhibitor) has been proposed for Xenopus (Stack and Newport, 1997; Hensey and Gautier, 1997; Sible et al., 1997; Anderson et al., 1997) . Alternatively, it is possible that the general capability for apoptosis is acquired at midgastrula stage as a consequence of the activation of specific genes or regulatory pathways (Hensey and Gautier, 1998) .
However, if an activation process is involved, then our data place a significant constraint on its possible mechanism. If a zebrafish embryo is exposed to camptothecin after 9 h of development, then some of its cells will become apoptotic within ϳ20 min of treatment (data not shown). The very fast nature of this response suggests that it does not require mRNA transcription. It seems more likely that a translational or posttranslational mechanism would be involved. For example, in the zebrafish embryo, the "sensing" and "effector" components of the apoptotic mechanism might involve either a second messenger such as a Ca 2ϩ flux or a posttranslational modification of some regulatory protein, for example, a phosphorylation event. Either of these mechanisms could operate on a time scale of seconds to minutes.
Exposure to DNA Replication Blockers before MBT: Similarity to Xenopus
We find, for the zebrafish embryo, that a pulse of camptothecin, aphidicolin, or hydroxyurea at the 4-to 8-cell stage will produce death in 100% of treated embryos, but only much later, at 8 -10 h (Figs. 7A, 8A , and 8B). This delayed response is similar to what is observed in Xenopus, for a pre-MBT treatment with cycloheximide (Hensey and Gautier, 1997; Sible et al., 1997) , ␥-irradiation (Hensey and Gautier, 1997; Anderson et al., 1997) , hydroxyurea (Stack and Newport, 1997) , emetine (Sible et al., 1997) , or ␣-amanitin (Sible et al., 1997) . We hypothesize that a transient, early pulse of camptothecin, aphidicolin, or hydroxyurea somehow will "mark" many cell nuclei in the zebrafish embryo for later destruction by apoptosis. The initial damage to the nuclei is low enough that the embryo can survive until mid-to late-gastrula stage; at this point, the apoptosis program is activated, and the embryo dies. The apoptotic response involves the phenotype of nuclear margination and fragmentation. It also involves profound changes in the cytoplasm, which ultimately produce an opaque white appearance, followed by lysis of the cells.
Differential effects of the replication blockers. The overall response of zebrafish embryos to an early (pre-MBT) treatment with camptothecin (an irreversible blocker of DNA replication) or to aphidicolin or hydroxyurea (reversible blockers of DNA replication) is the same: sudden death of embryos at 10 Ϯ 1.5 h. However, our experiments have revealed certain differences in the response to these agents, which we now discuss. (1) A camptothecin pulse at any time between 4-cell stage and shield stage will produce the death of all treated embryos, at the much later time of 10 Ϯ 1.5 h (Fig. 7A) . In contrast, aphidicolin or hydroxyurea will produce death of all embryos at 8 -10 h, only if given before the 8-cell stage; if aphidicolin or hydroxyurea are given after the 8-cell stage, then only a small fraction (20 -40%) of the treated embryos will die (Figs. 8A and 8B). (2) After MBT, aphidicolin has no apparent effect on embryos (i.e., it does not induce arrest of cell proliferation, apoptosis, or embryo death). In contrast, if camptothecin is given between MBT and early gastrula stage, then an arrest of cell proliferation will quickly occur, followed by apoptosis. We are not too surprised to find differences between the effects of camptothecin, aphidicolin, and hydroxyurea, because these agents block DNA replication by different mechanisms and could activate different checkpoint pathways. Thus, one must be cautious in trying to generalize about the zebrafish embryo's response to agents which have different molecular targets.
Comparison between zebrafish and Xenopus. The zebrafish embryo seems to exhibit a response very similar to that of the Xenopus embryo: if a DNA replication blocker is applied before MBT, then it will produce apoptosis much later, around 8 -10 h. However, there may be some differences between the two species of embryos. We find that hydroxyurea will produce apoptosis in the zebrafish embryo at gastrula stage, when given either before or after MBT (Fig.  8D , left and right, respectively). In contrast, it has been reported that, in Xenopus, hydroxyurea will produce gastrula-stage apoptosis when given before MBT, but not when given after MBT (Stack and Newport, 1997; Hensey and Gautier, 1997) . We suggest two possible explanations for this discrepancy.
(1) The assays in Xenopus may not have been sensitive enough to detect a low number of apoptotic cells per embryo. (2) The two species may differ in the efficacy of some compensating mechanism such as DNA repair, which could lead to nonapoptotic cell fates at midgastrula stage.
Similarities and Differences between Zebrafish and Mammalian Embryos
Comparative studies between fish and mammals point to a possible difference between embryos of lower and higher vertebrates, in the time during development when the capability for stress-or damage-induced apoptosis is acquired. In human and mouse embryos, apoptosis has been observed as early as the blastocyst stage, in the inner cell mass, in response to growth factor imbalance or trauma (Juriscova et al., 1996; Brison and Schultz, 1997) . This occurs at a distinctly earlier stage than midgastrula, when we first observe checkpoint-induced apoptosis in the zebrafish embryo and when this response is first observed in Xenopus.
Dynamic Behavior of Camptothecin-Treated DeepLayer Nuclei, before Entry into Apoptosis
Camptothecin treatment of gastrula-stage embryos causes an arrest of cell proliferation, with an immediate drop in the mitotic index to a value of zero (Fig. 1B and Ikegami et al., 1997a) . However, deep-layer cells which have become trapped outside of mitosis do not remain completely inert. Their nuclear volumes steadily increase (Fig. 6A) , and they continue to synthesize DNA (Figs. 6B and 6C) before ultimately becoming apoptotic. These behaviors could be due to either replicative or repair DNA synthesis. Nothing is known, in the zebrafish embryo, about the physiological or developmental control of different DNA polymerases, or about how the tasks of replicative and repair synthesis are apportioned between different DNA polymerases (see Wood and Shivji, 1997) .
We have been unable to determine the cell-cycle phase (G1, S, or G2) from which apoptosis is entered in response to camptothecin. Our experiments allow us to conclude only that the entry point for this response falls outside of mitosis. It may be necessary to obtain a deeper understanding of the zebrafish embryo's cell cycle before this question can be answered. In zebrafish, the MBT is associated with a lengthening of the cell cycle (Kane and Kimmel, 1982) and with acquisition of the G1 phase (Zamir et al., 1997) . However, it is not yet known when the G2 phase is acquired in any of the embryo's cell layers or cell lineages.
Apoptosis might be entered from different points in the cell cycle in the embryo's different cell layers or cell lineages. Mammalian cell lines show a considerable diversity with respect to the entry point for camptothecininduced apoptosis. In some mammalian cell lines, camptothecin produces a G 2 arrest (Tsao et al., 1992; Ryan et al., 1994; Maity et al., 1996) . However, in other mammalian cell lines, camptothecin induces an entry into apoptosis from a cell cycle phase other than G 2 . Thus in rat thymocytes, camptothecin induces apoptosis from G 0 (Bruno et al., 1992) . In contrast, in T-lymphocytes and in the A1.1 T-cell hybridoma line, camptothecin induces apoptosis from the G 1 /S boundary or from S phase (Cotter et al., 1992; Boehme and Lenardo, 1993) .
Lineage-and Tissue-Specificity of CamptothecinInduced Apoptosis
At the time when the capability for apoptosis is acquired (around midgastrula stage), the zebrafish embryo has differentiated into three mitotic domains (see Kane et al., 1992; Kimmel et al., 1995) . The capacity for camptothecininduced apoptosis appears to be roughly equivalent for all cells in the deep and enveloping cell layers. Camptothecin does not appear to induce apoptosis in the YSL. Relatively little is known about the yolk syncytial layer in teleost embryos. In zebrafish and killifish (Fundulus heteroclitus), the YSL forms when the yolk cell cytoplasm is invaded by nuclei from the blastomeres at the margin of the embryo (Kimmel and Law, 1985; Trinkaus, 1993) . The YSL nuclei undergo three to five rapid divisions and then become postmitotic. However, our Br-dU-incorporation experiments indicate clearly that, although the YSL nuclei exit from the mitotic cycle, they do not stop DNA synthesis.
After the end of gastrulation, different cell lineages and tissues in the embryo (derived from the deep and enveloping cell layers) begin to display significant differences in the response to camptothecin. We have conducted a number of pulse-chase experiments to determine the developmental windows of sensitivity which different cell lineages and tissues display, for camptothecin-induced apoptosis. These experiments will be discussed elsewhere. Here we note two points. (1) The first such difference is found between the embryo proper and the epithelial covering of the yolk. (2) Later in development, further differences are observed, which suggest that a critical variable may be the proliferative state of the lineage or tissue at the time of camptothecin treatment. We hypothesize that cells which have undergone terminal differentiation and have exited the cell cycle before the time of camptothecin treatment may be incapable of apoptosis by this agent.
Summary of Checkpoint-Related Milestones in Early Development of the Zebrafish Embryo
In this and two preceding papers (Ikegami et al., 1997a,b) , we have demonstrated the stepwise activation of mechanisms which allow the zebrafish embryo to respond appropriately to blocks on DNA or chromosome replication or to DNA damage. An overall summary of our findings is given in Fig. 11. (1) Before MBT, an "embryonic" type of cell cycle is operative, which is characterized by a rapid alternation between S and M phases and an apparent lack of checkpoints to monitor completion of these phases. (2) Between   FIG. 11 . Schematic diagram of checkpoint-related milestones in early zebrafish embryo development. Data are summarized from this paper and from Ikegami et al. (1997a,b) . (1) Before MBT, an "embryonic" type of cell cycle is operative, which is characterized by a rapid alternation between S and M phases and a lack of checkpoints for monitoring completion of these phases. (2) Between MBT and midgastrula stage, in response to an agent which interferes with S phase or M phase, cells in the zebrafish embryo can exhibit an arrest of cell proliferation, but not apoptosis. (3) After midgastrula stage, in response to an agent which interferes with S phase or M phase, cells of the zebrafish embryo respond by first undergoing an arrest of cell proliferation, followed by apoptosis.
MBT and midgastrula stages, in response to an agent which interferes with S or M phase, cells in the zebrafish embryo exhibit an arrest of cell proliferation, but not apoptosis. (3) After midgastrula stage, in response to certain agents which interfere with S or M phase, cells of the zebrafish embryo respond by undergoing apoptosis.
It appears that, in zebrafish, the general phenomenon of phased checkpoint activation may have both similarities and differences to that of Xenopus (see Stack and Newport, 1997; Sible et al., 1997; Hensey and Gautier, 1997; Anderson et al., 1997) . These two model systems could be exploited in a way that takes advantage of the strengths of each, to gain further insight into this aspect of the embryology of the lower vertebrates. Biochemical studies could be conducted in Xenopus with the aim of purifying the proteins which mediate these responses. In a complementary fashion, genetic screens could be conducted in zebrafish, to identify mutants which are unable to respond appropriately to checkpoint-inducing agents or stresses.
